arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

BeyondSpring Inc.

BYSI
$0.75 ▲ +0.02 (+2.81%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
20 Visible periods
23 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Neutral
auto_awesome

Analytical Summary

BeyondSpring Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $30.8M
Dividend Yield
Revenue Growth
Op. Margin
ROIC 5.2%
FCF / Share $-0.09
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 21, 2026.

20-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
Net Income Profit after all expenses
$-849.00K
↑ +53.0%
FCF / Share Free cash flow per share
$-0.09
↓ -15.1%
Long-Term Debt Long-term obligations
$0.00
↓ -100.0%

Health Breakdown

Returns
50
Cash Quality
99

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 12 years · 20 quarters